-
Mashup Score: 1
Those with dense breasts have less fatty tissue and more glandular tissue, which is tissue that produces breast milk. Learn why it raises your breast cancer risk.
Source: www.henryford.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
FLASH-RT can offer better tumor cell-killing efficacy, but a better understanding of the molecular responses and optimal dose rates are needed.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5What Is Cancer? - 2 year(s) ago
Explanations about what cancer is, how cancer cells differ from normal cells, and genetic changes that cause cancer to grow and spread.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
A phase 1 clinical trial could provide biomarker clues to help guide future studies.
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Breast conservation safe even with multiple-site tumors - 2 year(s) ago
“This is an important study confirming that breast conservation is feasible and safe for women with multiple ipsilateral breast cancers, with excellent results comparable to those for women with unifocal disease.”
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4
Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) provided significant antitumor activity in various tumors, mainly carrying deleterious mutations of BRCA1/BRCA2 genes. Only few data are available regarding the cardiac and vascular safety profile of this drug class. We carried out a meta-analysis for assessing the incidence and relative risk (RR) of major adverse cardiovascular events…
Source: Esmo OpenCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Trastuzumab deruxtecan induces durable responses in HER2-expressing advanced solid tumors - 2 year(s) ago
A phase 2 trial of trastuzumab deruxtecan met a prespecified target for objective response rate and showed clinically meaningful, durable responses across multiple HER2-expressing advanced solid tumors, according to a company press release.Trastuzumab deruxtecan (Enhertu; AstraZeneca, Daiichi Sankyo), an HER2-directed antibody-drug conjugate approved for certain patients with breast, lung and
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI - 2 year(s) ago
Background and Objectives Internal neurofibromas, including plexiform neurofibromas (PNF), can cause significant morbidity in patients with neurofibromatosis type 1 (NF1). PNF growth is most pronounced in children and young adults, with more rapid growth thought to occur in a subset of PNF termed distinct nodular lesions (DNL). Growth behavior of internal neurofibromas and DNL in older adults is…
Source: NeurologyCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0Women younger than 55 years have a 2.4% higher incidence of pancreatic cancer vs. men - 2 year(s) ago
The incidence of pancreatic cancer increased at a faster rate over time among women aged younger than 55 years compared with their male counterparts, according to research published in Gastroenterology. “A previously published nationwide study by our team showed that the incidence of pancreatic cancer has been significantly increasing in younger women at a greater rate compared to younger
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0Study Examines Whether Blood Test Can Identify Early Cancers - 2 year(s) ago
A blood test combined with imaging tests detected tumors—some at an early stage—in women without a history of cancer or any symptoms, a recent study showed. The liquid biopsy, called CancerSEEK, also mistakenly indicated some women had cancer when additional testing determined they did not.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Dense breast tissue makes it difficult to detect #tumors on a #mammogram. While a mammogram detects 98% of cancers in women with fatty breasts, it finds only 48% in women with extremely dense breasts: https://t.co/kvw1AMNwVK